Ramsay David A
- SEC CIK
- 0001283292
In the past year, 1 open-market sale filing worth $121.2K and no purchases.
Current role at each company
- HALO Halozyme Therapeutics, Inc.EVP, PRESIDENT, DRUG DELIVERYas of Jul 2, 2026
- SVRA Savara IncDirectoras of Dec 19, 2025
- LJPC La Jolla Pharmaceutical CoDirectoras of Aug 24, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $121.2K
- 1 filing
- Net
- −$121.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Ramsay David A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SVRA Savara Inc
Director24 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 (view filing) | Dec 19 | Same day | Ramsay David ADirector | SSale | −20.0K | $6.06 | −$121.2K | −0.8%2.53M after | |
| Apr 1, 2025 (view filing) | Mar 31 | 1 day | Ramsay David ADirector | PPurchase | +150.0K | $2.78 | +$417.0K | +6.3%2.51M after | |
| Nov 18, 2024 (view filing) | Nov 18 | Same day | Ramsay David ADirector | PPurchase | +100.0K | $2.88 | +$288.0K | +4.5%2.32M after | |
| May 26, 2023 (view filing) | May 24-26 | 2 days | Ramsay David ADirector | PPurchase | +100.0K | $2.59 | +$258.7K | +4.8%2.20M after | 3 lots |
| Jan 3, 2023 (view filing) | Dec 29-30, 2022 | 5 days | Ramsay David ADirector | PPurchase | +36.0K | $1.55 | +$55.7K | +1.7%2.10M after | 2 lots |
| Dec 28, 2022 (view filing) | Dec 23-28 | 5 days | Ramsay David ADirector | PPurchase | +19.0K | $1.45 | +$27.6K | +0.9%2.07M after | 2 lots |
| Dec 22, 2022 (view filing) | Dec 20-22 | 2 days | Ramsay David ADirector | PPurchase | +45.0K | $1.48 | +$66.6K | +2.2%2.05M after | 2 lots |
| Dec 20, 2022 (view filing) | Dec 16-20 | 4 days | Ramsay David ADirector | PPurchase | +54.9K | $1.49 | +$81.9K | +2.8%2.00M after | 3 lots |
| Nov 25, 2022 (view filing) | Nov 22-23 | 3 days | Ramsay David ADirector | PPurchase | +20.1K | $1.42 | +$28.6K | +1.0%1.95M after | 2 lots |
| Nov 21, 2022 (view filing) | Nov 17-21 | 4 days | Ramsay David ADirector | PPurchase | +50.0K | $1.37 | +$68.4K | +2.7%1.93M after | 3 lots |
LJPC La Jolla Pharmaceutical Co
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2021 (view filing) | Dec 2-6 | 4 days | Ramsay David ADirector | PPurchase | +24.5K | $3.75 | +$92.0K | +32.5%100.0K after | 18 lots |
| Nov 19, 2021 (view filing) | Nov 17 | 2 days | Ramsay David ADirector | PPurchase | +7.50K | $4.23 | +$31.7K | +11.0%75.5K after |